Literature DB >> 16927822

[Mechanism of oral absorption of panaxnotoginseng saponins].

Min Han1, Li-Mei Han, Qing-Song Wang, Zhi-Hua Bai, Xiao-Ling Fang.   

Abstract

AIM: To study the mechanism of absorption after oral administration of panaxnotoginseng saponins (PNS).
METHODS: Caco-2 cells and rat models were applied to evaluate the degradation of both ginsenoside Rb1 (Rb1) and ginsenoside Rg1 (Rg1) in PNS in gastrointestinal lumen, and the transport mechanism of PNS across the intestinal mucosa, and the barrier function of stomach, intestine and liver involved in absorption process.
RESULTS: Rb1 and Rg1 proved to be readily eliminated in stomach, but stable in relatively neutral circumstance. Both Rb1 and Rg1 in PNS, especially for Rb1, degraded significantly in the contents of large intestine. However, both of them kept mainly intact in the contents of small intestine. Uptake of both Rb1 and Rg1 by Caco-2 cell monolayer was inhibited at low temperature, but not by cyclosporine A, and the change in the apical pH showed no pronounced effect. Uptake and transport were non-saturable and increased linearly with increasing of concentrations of Rb1 and Rg1 over the range of concentration tested, which indicated a passive transport. There was no significant difference of absorption characteristic between monomer (Rb1 and Rg1) and mixture (PNS). Uptake amount of Rg1 [(1.07 +/- 0.16) microg x mg(-1) (protein)] (C0 = 1 mg x mL(-1)) in Caco-2 cells was a little higher than that of Rb1 [(0.77 +/- 0.03) microg x mg(-1) (protein)] (C0 = 1 mg x mL(-1)). Meanwhile, apparent permeability coefficient of (5.9 +/- 1.0) x 10(-8) cm x s(-1) (C0 = 1 mg x mL(-1)) for Rb1 and (2.59 +/- 0.17) x 10(-7) cm x s(-1) (C0 = 1 mg x mL(-1)) for Rg1 from apical compartment to basolateral compartment predicted an incompletely absorption. Transports of both Rb1 and Rg1 were not influenced by cyclosporine A. The investigation on the pharmacokinetic behavior of Rb1 and Rg1 after different routes of administration to rats showed that the absolute bioavailability after peroral (po), intraduodenal (id), and portal venous (pv) administration is 0.71% , 2.75% and 65.77% respectively for Rb1, and 3.29%, 6.60% and 50.56% respectively for Rg1.
CONCLUSION: Transport across Caco-2 cell monolayer for PNS (include Rb1 and Rg1) is a simple passive diffusion process. No efflux transporters in Caco-2 cells and other components in PNS showed effects on it. The elimination in stomach, large intestine and liver contributed to the low bioavailability of PNS, but the low membrane permeability might be a more important factor dominating the extent of absorption.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16927822

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  5 in total

1.  Pharmacokinetics of Panax notoginseng Saponins in Adhesive and Normal Preparation of Fufang Danshen.

Authors:  Xiao-Nan Chen; Dan-Qi Li; Meng-di Zhao; Gang-Yan Yu; Shou-Ying Du; Yang Lu; Jie Bai; Peng-Yue Li; Ya-Li Wu; Zhi-Hao Tian; Yan-Ying Zeng
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-04       Impact factor: 2.441

2.  Rapid but mild genoprotective effect on lymphocytic DNA with Panax notoginseng extract supplementation.

Authors:  Yim Tong Szeto; Loretta Kit Yee Lee
Journal:  J Intercult Ethnopharmacol       Date:  2014-08-26

3.  Absorption and Transport of Sea Cucumber Saponins from Apostichopus japonicus.

Authors:  Shuai Li; Yuanhong Wang; Tingfu Jiang; Han Wang; Shuang Yang; Zhihua Lv
Journal:  Mar Drugs       Date:  2016-06-17       Impact factor: 5.118

Review 4.  Effect of Panax notoginseng Saponins and Major Anti-Obesity Components on Weight Loss.

Authors:  Xuelian Zhang; Bin Zhang; Chenyang Zhang; Guibo Sun; Xiaobo Sun
Journal:  Front Pharmacol       Date:  2021-03-25       Impact factor: 5.810

5.  Core-shell hybrid liposomal vesicles loaded with panax notoginsenoside: preparation, characterization and protective effects on global cerebral ischemia/reperfusion injury and acute myocardial ischemia in rats.

Authors:  Jing Zhang; Xizhen Han; Xiang Li; Yun Luo; Haiping Zhao; Ming Yang; Bin Ni; Zhenggen Liao
Journal:  Int J Nanomedicine       Date:  2012-08-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.